Enveric Biosciences annual debt-to-assets ratio
2015
2016
2017
2018
2019
2021
2022
2023
Enveric Biosciences Debt-to-Assets Ratio Growth & History (ENVB)
Enveric Biosciences's debt-to-assets ratio was 0.00 for fiscal 2023.
View full Enveric Biosciences company overviewEnveric Biosciences annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 0.00 | −0.00 | — |
| 2022 | 2022-12-31 | 0.00 | −0.00 | −50.53% |
| 2021 | 2021-12-31 | 0.01 | — | — |
| 2019 | 2019-12-31 | 0.23 | 0.19 | +454.17% |
| 2018 | 2018-12-31 | 0.04 | 0.02 | +94.72% |
| 2017 | 2017-12-31 | 0.02 | −0.11 | −82.99% |
| 2016 | 2016-12-31 | 0.13 | −0.23 | −64.77% |
| 2015 | 2015-12-31 | 0.36 | — | — |
Enveric Biosciences quarterly debt-to-assets ratio
Q2.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2023 | 2023-06-30 | 0.00 | −0.00 | −76.84% |
| Q1 2023 | 2023-03-31 | 0.00 | −0.00 | −50.31% |
| Q4 2022 | 2022-12-31 | 0.00 | −0.00 | −50.53% |
| Q3 2022 | 2022-09-30 | 0.00 | — | — |
| Q2 2022 | 2022-06-30 | 0.00 | — | — |
| Q1 2022 | 2022-03-31 | 0.00 | — | — |
| Q4 2021 | 2021-12-31 | 0.01 | — | — |
| Q3 2020 | 2020-09-30 | 0.03 | −0.01 | −28.23% |
| Q2 2020 | 2020-06-30 | 0.03 | −0.02 | −33.02% |
| Q1 2020 | 2020-03-31 | 0.04 | 0.00 | +12.42% |
| Q4 2019 | 2019-12-31 | 0.23 | 0.19 | +454.17% |
| Q3 2019 | 2019-09-30 | 0.04 | 0.04 | +26241.54% |
| Q2 2019 | 2019-06-30 | 0.05 | 0.02 | +70.01% |
| Q1 2019 | 2019-03-31 | 0.03 | 0.00 | +9.45% |
| Q4 2018 | 2018-12-31 | 0.04 | 0.02 | +94.72% |
| Q3 2018 | 2018-09-30 | 0.00 | −0.04 | −99.60% |
| Q2 2018 | 2018-06-30 | 0.03 | −0.01 | −20.42% |
| Q1 2018 | 2018-03-31 | 0.03 | 0.00 | +4.52% |
| Q4 2017 | 2017-12-31 | 0.02 | −0.11 | −82.99% |
| Q3 2017 | 2017-09-30 | 0.04 | 0.00 | +2.28% |
| Q2 2017 | 2017-06-30 | 0.04 | −0.33 | −89.87% |
| Q1 2017 | 2017-03-31 | 0.03 | −0.41 | −93.42% |
| Q4 2016 | 2016-12-31 | 0.13 | −0.23 | −64.77% |
| Q3 2016 | 2016-09-30 | 0.04 | — | — |
| Q2 2016 | 2016-06-30 | 0.36 | −0.12 | −24.19% |
| Q1 2016 | 2016-03-31 | 0.44 | — | — |
| Q4 2015 | 2015-12-31 | 0.36 | — | — |
| Q2 2015 | 2015-06-30 | 0.48 | — | — |
Enveric Biosciences debt-to-assets ratio trends
Over the last five fiscal years, Enveric Biosciences's debt-to-assets ratio decreased from 0.04 to 0.00, a change of −0.04. The latest reported quarter, Q2 2023, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Enveric Biosciences source filings ↗